Navigation Links
Celladon Corporation Announces Pre-clinical Study Demonstrating Inhalable MYDICAR Reverses Pulmonary Arterial Hypertension (PAH)
Date:7/30/2013

Janet C. Ross Professor of Medicine and Professor of Gene & Cell at Icahn School of Medicine at Mount Sinai. "We are excited about testing this therapy in PAH patients who are in critical need of intervention."

This same SERCA2a dysfunction also occurs in heart failure. This new study utilizes Celladon's product candidate MYDICAR which is currently under investigation in an international 200 patient Phase IIb trial in the United States and Europe. In 2012, Celladon and the Mt. Sinai School of Medicine entered into a license agreement granting Celladon certain exclusive worldwide rights to develop and commercialize SERCA2a gene therapy products for PAH.

"What we have shown is that gene therapy restores function of this crucial SERCA2a enzyme in diseased lungs," says Dr. Hajjar. "We are delighted with these new findings because it suggests that MYDICAR which is already showing great benefit in congestive heart failure patients may be able to help PAH patients who currently have no good treatment options — and are in critical need of a life sustaining therapy."

When SERCA2a is down-regulated, calcium stays longer in the cells than it should, and it induces pathways that lead to overgrowth of new and enlarged cells. According to researchers, the delivery of the SERCA2a gene through the MYDICAR product in turn produces SERCA2a enzymes, which helps both heart and lung cells restore their proper use of calcium.

"We are now on a path toward PAH patient clinical trials in the near future," says Dr. Hajjar, a co-founder of Celladon who developed the gene therapy approach. Studies in large animal models are now underway. SERCA2a gene therapy has already been approved by the National Institutes of Health for human study.

A Simple MYDICAR Inhalation Corrects Deadly Dysfunction
PAH most commonly results from heart failure in the left side of the heart or from a pulmonary embol
'/>"/>

SOURCE Celladon Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Celladon Corporation Named a 2012 Fierce 15 Company by FierceBiotech
2. Celladon Corporation To Present at BioCentury Future Leaders in the Biotech Industry Conference
3. Celladon Corporation and SIRO Clinpharm Announce Presentation at "Statisticians in the Pharmaceutical Industry International Conference"
4. Celladon Corporation Selected as Winner of Red Herrings "Top 100 North America Tech Startup"
5. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
6. Kensey Nash Corporation Announces Achievement of $6 Million Milestone From Spectranetics Corporation
7. China Cord Blood Corporation Announces Results of 2011 Annual General Meeting
8. Neogen Corporation Announces 2nd Quarter Results Conference Call
9. Luminex Corporation to Present at JP Morgan Healthcare Conference
10. Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012
11. Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... (PRWEB) September 17, 2014 Beckman ... advances science and healthcare, has renewed its agreement with ... As part of the agreement, Personify will continue to ... sustained emphasis on recruitment analytics, including time-to-fill, time-to-source and ... renew our agreement with Personify was based on the ...
(Date:9/17/2014)... NASA’s MESSENGER has just celebrated its 10 year ... have one of its latch valves, V27200-818, operating onboard ... investigation of the planet Mercury. It is only the ... provided a vast amount of information and images of ... utilize solenoids that also include permanent magnets to maintain ...
(Date:9/16/2014)... “Nature has developed, very cleverly, some lessons ... in optical design,” said Joseph Shaw, director of the ... explore surfaces and structures at the nanoscale, we’ll discover ... San Diego in August during a conference called “ ... by Shaw and Rongguang Liang of the University of ...
(Date:9/16/2014)... 16, 2014  Biocom, the association representing the ... the 9 th Annual National Health Information Technology ... technologies in improving our health care system. ... of the world,s most vibrant hubs for health IT ... applications to genomic testing to remote patient monitoring," said ...
Breaking Biology Technology:Beckman Coulter Signs 3-year RPO Contract with Personify 2Beckman Coulter Signs 3-year RPO Contract with Personify 3Nature’s designs inspire research into new light-based technologies 2Nature’s designs inspire research into new light-based technologies 3Nature’s designs inspire research into new light-based technologies 4Nature’s designs inspire research into new light-based technologies 5Biocom Recognizes National Health IT Week 2
... Salk Institute is pleased to announce the appointment of ... Salk Institute Office of Technology Development. His appointment begins ... experience in academic technology transfer.  For over a decade ... Patent Foundation, where he led a broad expansion and ...
... Volcano Corporation (Nasdaq: VOLC ), a leading ... to enhance the diagnosis and treatment of coronary and ... to market the Eagle Eye® Platinum digital IVUS catheter ... 20th PCI Live Demonstration Course in Kurashiki, which starts ...
... 2011 Healthzone Limited (ASX: HZL; OTCQX: HLTZY) announced ... The Trout Group LLC ("the Trout Group"), a leading ... Trout Group will provide investor relations services for Healthzone ... With more than 60 current clients, the Trout Group ...
Cached Biology Technology:Salk Welcomes National Leader in Academic Technology Transfer 2Volcano Announces the Introduction of the Eagle Eye® Platinum Digital IVUS Catheter at the 20th PCI Live Demonstration Course in Kurashiki 2Volcano Announces the Introduction of the Eagle Eye® Platinum Digital IVUS Catheter at the 20th PCI Live Demonstration Course in Kurashiki 3Healthzone Limited Engages The Trout Group for Investor Relations Services 2
(Date:9/16/2014)... began on September 13, 2014. The fire is human-caused ... over 2,300 acres in size and is mostly being ... was calm Monday night due to higher humidity. ... and beginning to construct a fireline on the West and ... working on the fire: , 7 20-person Crews, 4 Hot ...
(Date:9/16/2014)... 10-km diameter chunk of rock hit the Yukatan peninsula near ... force of 100 teratons of TNT. It left a crater ... global earthquakes and volcanism are widely accepted to have wiped ... the mammals. But what happened to the plants on which ... from the University of Arizona reveals that the meteorite impact ...
(Date:9/16/2014)... week, its Government could face an uphill challenge in ... has revealed. , The University of Nottingham Shale Gas ... extraction in the UK since March 2012 and has ... the least supportive of fracking. , Professor Sarah O,Hara, ... Geography, said: "The clear move against shale gas extraction ...
Breaking Biology News(10 mins):Meteorite that doomed the dinosaurs helped the forests bloom 2Meteorite that doomed the dinosaurs helped the forests bloom 3Scottish people most sceptical on fracking, survey shows 2Scottish people most sceptical on fracking, survey shows 3
... study shows that personal values that people refuse to disavow, ... in the brain than those values that are willingly sold. ... whether it,s a strong religious belief, a national identity ... process," says Gregory Berns, director of the Center for Neuropolicy ...
... Doctors and researchers of Hospital del Mar and ... describing a new pharmacological resistance to cancer. This new ... (epidermal growth factor receptor) causing resistance to treatment using ... attacks the EGFR. The study proves that, both ...
... RIKEN SPring-8 Center in Harima, Japan have clarified the ... a bacterial enzyme that offers clues on the origins ... importance to fundamental science, the findings provide key insights ... greenhouse gas hundreds of times more potent than carbon ...
Cached Biology News:The price of your soul: How the brain decides whether to 'sell out' 2The price of your soul: How the brain decides whether to 'sell out' 3Identified a cause of resistance to colon cancer treatment 2New study sheds light on evolutionary origin of oxygen-based cellular respiration 2
... Immunogen: Fusion protein derived from human ... (atypical PKC isotype-specific interacting protein/ partitioning ... related to the protease-activated-receptors also called ... (positive controls: Caco-2 MDCK A6 cell ...
For use with SSP products or any application requiring agarose gel separation • Multiple formats available to meet various throughput needs • Includes replacement parts for each un...
Request Info...
Human RUNX2/CBFA1 MAb (Clone 232902)...
Biology Products: